Navigation Links
Caliper Life Sciences Reports First Quarter 2009 Results
Date:4/30/2009

approximately 6%. Research growth was strong, primarily due to sales of the proprietary LabChip GX, which the Company believes is the "best-in-class" proprietary solution for characterizing proteins in the fast growing biologicals market, and increased sales of Profiler Pro reagent kits which are used for kinase screening with the EZ Reader instrument.
  • Optical Imaging revenues increased to $10.7 million during the first quarter of 2009 from $9.8 million during the first quarter of 2008. This increase represented organic growth of 15% before unfavorable currency effects of approximately 5%. Optical Imaging growth was driven by continued strong global demand for IVIS instruments and accessories, reagents and services.
  • Caliper's Discovery Alliances and Services (CDAS) revenues decreased by 7% (unaffected by currency changes) to $4.2 million during the first quarter of 2009 from $4.5 million during the first quarter of 2008. The net decrease resulted from a decrease in in vitro services revenues partially offset by in vivo services revenue improvement. The Company anticipates revenue from CDAS services to grow over the second half of 2009 based on the expectation that it will receive a new task order under the Environmental Protection Agency's ToxCast(R) program.
  • Total gross margin decreased by approximately 1% during the first quarter of 2009 compared to same period in 2008 primarily due to the loss of service margin contribution that was associated with the product lines that were divested in the fourth quarter of 2008.
  • Operating expenses (research and development plus selling, general and administrative expenses) decreased by 19% to $15.7 million during the first quarter of 2009 from $19.5 million in the first quarter of 2008. This reduction included $2.8 million of SG&A expense reduction and $1.0 million of R&D expense reduction resulting from streamlining
    '/>"/>

  • SOURCE Caliper Life Sciences, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
    2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
    3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
    4. Caliper Life Sciences Presentation at UBS Global Life Sciences Conference to be Webcast
    5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
    6. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
    7. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
    8. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference
    9. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today
    10. Caliper Life Sciences to Present at Deutsche Bank 2008 Small and Mid Cap Growth Conference
    11. Caliper Life Sciences Fourth Quarter 2007 Financial Results Conference Call Notice
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... Rockville, MD (PRWEB) August 21, 2014 ... is making progress in its development of JRC-LAMP-vax, an ... red cedar pollen. Phase IC studies began this month ... solution to hay fever. , The Japanese red cedar ... million people in Japan. Mountain Cedar pollen wreaks similar ...
    (Date:8/21/2014)... 21, 2014 His Majesty Willem-Alexander, King ... The Court of His Majesty Willem-Alexander, King of the ... Grand Opening of POET-DSM Advanced Biofuels’ Project LIBERTY cellulosic ... , The King will take part in the Grand ... for 11 a.m.-12:20 p.m. and tour the plant. POET-DSM ...
    (Date:8/21/2014)... Aug. 21, 2014 OTC Markets ... Inc., a biotechnology company, on its approval to ... traded on OTCQX®, the best marketplace for established ... Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... successful execution of its growth strategy and achievement ...
    (Date:8/21/2014)... St. Louis, MO (PRWEB) August 21, 2014 ... premier, full service biopharmaceutical contract development and manufacturing ... selected by Progenics Pharmaceuticals, Inc., an oncology company ... targeting and treating cancer, to manufacture the anti-prostate ... Progenics’ PSMA ADC product candidate. Under the ...
    Breaking Biology Technology:Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3
    ... , , , AUSTIN, Texas, Jan. ... announced its predictions for key trends and merger and acquisition ... the oil and gas sector for 2010. Bender Consulting combines ... transformation initiatives for High Tech, Energy and Bio Tech clients. ...
    ... , MADEIRA BEACH, Fla. , ... Mr. Diabetes®, Executive Director of Defeat Diabetes Foundation and diabetes ... ProtoKinetix (PKTX) Advisory Board.  ProtoKinetix, Inc. is a biotechnology company ... glycoproteins (AAGP™) for medicine and the biotechnology and cosmetic industries. ...
    ... Million EUR 2008 08/07 2009 ... MEUR %Sales Var.% MEUR %Sales Var.%, Southern Europe (1) ... countries (2) 11.3 23 17 13.1 23 ... 1.5 3 (25), SLIT ...
    Cached Biology Technology:Bender Consulting Predicts Key Trends and Merger and Acquisition Activity for the Oil & Gas Sector in 2010 2Bender Consulting Predicts Key Trends and Merger and Acquisition Activity for the Oil & Gas Sector in 2010 3Andrew P. Mandell - Mr. Diabetes(R) to Sit On ProtoKinetix Advisory Board 2STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13% 2STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13% 3
    (Date:8/21/2014)... the Fram Strait is a key region in the global ... Greenland and Svalbard warm Atlantic water flows to the north ... Arctic water masses and sea ice push their way out ... of the Atlantic water cools here on its way to ... the water caused in this manner drives the global band ...
    (Date:8/21/2014)... of researchers at Louisiana Tech University has ... consumer-grade 3D printers and materials to fabricate ... and chemotherapeutic compounds for targeted drug delivery. ... and research faculty from Louisiana Tech,s biomedical ... create filament extruders that can make medical-quality ...
    (Date:8/20/2014)... of 158 pregnant teenagers in Rochester, NY, nearly half ... of ice, cornstarch, vacuum dust, baby powder and soap, ... , Moreover, such teens had significantly lower iron levels ... substances. , Pregnant teens, regardless of pica, are at ... iron deficiency and anemia. Low iron in pregnant teens ...
    Breaking Biology News(10 mins):Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Pica in pregnant teens linked to low iron 2
    ... of what makes some people stand head and shoulders above ... the first common version of a gene influencing height has ... together can make a height difference of up to 6cm. ... online today in the journal Nature Genetics, mean that scientists ...
    ... Those spindly plants that desperately try to reach for a ... from the same affliction: Shade avoidance syndrome or SAS. Now, ... by researchers at the Salk Institute for Biological Studies. ... on a natural chemical factory for the synthesis of the ...
    ... at the Burnham Institute for Medical Research (Burnham) may ... therapy by showing the link between a certain protein ... feed breast tumors. Like mortar between bricks in a ... together and collectively form tissues. Cancer cells that loosen ...
    Cached Biology News:A tall story: New research adds to growing body of knowledge of genetics of height 2A place in the sun 2A place in the sun 3T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role 2T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role 3
    Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
    TXNL2 Antibody...
    Rat polyclonal to Vitamin B3 ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule, Vitamin B3 conjugated to BSA....
    Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
    Biology Products: